Trial intelligence / Profile preview

WARCEF: Warfarin vs Aspirin in Reduced Ejection Fraction

NCT00041938Phase 3Completed

Sponsor
Columbia University
Start
Oct 2002
Primary completion
Aug 2011
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of warfarin in heart failure (HF), sponsored by Columbia University. Started Oct 2002; status: completed.

02

Drugs

warfarin
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00041938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00041938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call